SEARCH

SEARCH BY CITATION

References

  • 1
    Craft RM, Chavez JJ, Bresee SJ, et al. A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004; 143(5):301309.
  • 2
    Brainard BM, Kleine SA, Papich MG, et al. Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs. Am J Vet Res 2010; 71(7):822830.
  • 3
    Flatland B, Fry MM, Baek SJ, et al. May-Hegglin anomaly in a dog. Vet Clin Pathol 2011; 40(2):207214.
  • 4
    Conner BJ, Hanel RM, Hansen BD, et al. Effects of acepromazine maleate on platelet function assessed by use of adenosine diphosphate activated- and arachidonic acid-activated modified thromboelastography in healthy dogs. Am J Vet Res 2012; 73(5):595601.
  • 5
    Blois SL, Banerjee A, Wood RD. Evaluation of thrombelastographic platelet-mapping in healthy cats. Vet Clin Pathol 2012; 41(2):223227.
  • 6
    Brooks MB, Divers T, Watts AE, et al. A randomized study of the effects of clopidogrel on parameters of equine platelet activation response. Am J Vet Res 2013; 74(9):12121222.
  • 7
    Kalbantner K, Baumgarten A, Mischke R. Measurement of platelet function in dogs using a novel impedance aggregometer. Vet J 2010; 185(2):144151.
  • 8
    Greene CE. Effects of aspirin and propranolol on feline platelet aggregation. Am J Vet Res 1985; 46(9):18201823.
  • 9
    Park FM, Blois SL, Abrams-Ogg ACG, et al. Hypercoagulability and ACTH-dependent hyperadrenocorticism in dogs. J Vet Int Med 2013; 27(5):1136--1142.
  • 10
    Johnson GJ, Leis LA, Dunlop PC. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction. J Clin Invest 1993; 92(5):24692479.
  • 11
    Cathcart CJ, Brainard BM, Reynolds LR, et al. Lack of inhibitory effect of acetylsalicylic acid and meloxicam on whole blood platelet aggregation in cats. J Vet Emerg Crit Care 2012; 22(1):99106.
  • 12
    Konishi N, Hiroe K, Kawamura M. Synergistic effect of a factor Xa inhibitor, TAK-442, and antiplatelet agents on whole blood coagulation and arterial thrombosis in rats. Thromb Res 2010; 126(2):124129.
  • 13
    Tantry US, Bliden KP, Gurbel PA. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol 2005; 46(9):17051709.
  • 14
    DiChiara J, Bliden KP, Tantry US, et al. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. Diabetes 2007; 56(12):30143019.
  • 15
    Dichiara J, Bliden KP, Tantry US, et al. Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients. Platelets 2007; 18(6):414423.
  • 16
    Carroll RC, Worthington RE, Craft RM, et al. Post interventional cardiology urinary thromboxane correlates with PlateletMapping detected aspirin resistance. Thromb Res 2010; 125(4):e118e122.
  • 17
    Agarwal S, Coakley M, Reddy K, et al. Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry. Anesthesiology 2006; 105(4):676683.
  • 18
    Hobson AR, Petley G, Morton G, et al. Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with drug-eluting stent thrombosis whilst on dual antiplatelet therapy. Thromb J 2008; 6:1.
  • 19
    Cotton JM, Worrall AM, Hobson AR, et al. Individualised assessment of response to clopidogrel in patients presenting with acute coronary syndromes: a role for short thrombelastography? Cardiovasc Ther 2010; 28(3):139146.
  • 20
    Frelinger AL, 3rd, Jakubowski JA, Li Y, et al. The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities. J Thromb Haemost 2008; 6(2):359365.
  • 21
    Kwak YL, Kim JC, Choi YS, et al. Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. J Am Coll Cardiol 2010; 56(24):19942002.
  • 22
    Preisman S, Kogan A, Itzkovsky K, et al. Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery. Eur J Cardiothorac Surg 2010; 37(6):13671374.
  • 23
    Mahla E, Suarez TA, Bliden KP, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 2012; 5(2):261269.
  • 24
    Gurbel PA, Bliden KP, Antonino MJ, et al. The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patients. J Thromb Haemost 2010; 8(1):4353.
  • 25
    Nielsen AB, Bochsen L, Steinbruchel DA. Hypercoagulability and platelet inhibition after OPCAB. Randomized intervention with clopidogrel. Scand Cardiovasc J 2007; 41(5):325330.
  • 26
    Alstrom U, Tyden H, Oldgren J, et al. The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment. Thromb Res 2007; 120(3):353359.
  • 27
    Collyer TC, Gray DJ, Sandhu R, et al. Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thrombelastography Platelet Mapping. Br J Anaesth 2009; 102(4):492498.
  • 28
    Liu L, Cao J, Fan L, et al. Prevalence and risk factors for aspirin resistance in elderly patients with type 2 diabetes. Int J Gerontol 2011; 5(2):112116.
  • 29
    Frelinger AL, Li Y, Linden MD, et al. Aspirin ‘resistance’: role of pre-existent platelet reactivity and correlation between tests. J Thromb Haemost 2008; 6(12):20352044.
  • 30
    Alstrom U, Granath F, Oldgren J, et al. Platelet inhibition assessed with VerifyNow, flow cytometry and PlateletMapping in patients undergoing heart surgery. Thromb Res 2009; 124(5):572577.
  • 31
    Gurbel PA, Bliden KP, Navickas IA, et al. Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events. Am Heart J 2010; 160(2):346354.
  • 32
    Bliden KP, DiChiara J, Tantry US, et al. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? J Am Coll Cardiol 2007; 49(6):657666.
  • 33
    Garcia-Rinaldi R, Carro-Pagan C, Schaff HV, et al. Initial experience with dual antiplatelet thromboprophylaxis using clopidogrel and aspirin in patients with mechanical aortic prostheses. J Heart Valve Dis 2009; 18(6):617625; discussion 626.
  • 34
    Poston R, Gu J, Manchio J, et al. Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting. Eur J Cardiothorac Surg 2005; 27(4):584591.
  • 35
    Scharbert G, Auer A, Kozek-Langenecker S. Evaluation of the PlateletMapping assay on rotational thromboelastometry ROTEM. Platelets 2009; 20(2):125130.
  • 36
    Solomon C, Sorensen B, Hochleitner G, et al. Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry. Anesth Analg 2012; 114(4):721730.
  • 37
    Lang T, Toller W, Gutl M, et al. Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost 2004; 2(1):147153.
  • 38
    Fluger I, Maderova K, Simek M, et al. The effect of a cardiopulmonary bypass system with biocompatible coating on fibrinogen levels determined by the TEG–functional fibrinogen method: preliminary results. Perfusion 2011; 26(6):503509.
  • 39
    Khurana S, Mattson JC, Westley S, et al. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997; 130(4):401411.
  • 40
    Parker RJ, Eley KA, Von Kier S, et al. Functional fibrinogen to platelet ratio using thromboelastography as a predictive parameter for thrombotic complications following free tissue transfer surgery: a preliminary study. Microsurgery 2012; 32(7):512519.
  • 41
    Kettner SC, Panzer OP, Kozek SA, et al. Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesth Analg 1999; 89(3):580584.
  • 42
    Chakroun T, Gerotziafas GT, Seghatchian J, et al. The influence of fibrin polymerization and platelet-mediated contractile forces on citrated whole blood thromboelastography profile. Thromb Haemost 2006; 95(5):822828.
  • 43
    Carroll RC, Craft RM, Chavez JJ, et al. Measurement of functional fibrinogen levels using the Thrombelastograph. J Clin Anesth 2008; 20(3):186190.
  • 44
    Brainard BM, Abed JM, Koenig A. The effects of cytochalasin D and abciximab on hemostasis in canine whole blood assessed by thromboelastography and the PFA-100(R) platelet function analyzer system. J Vet Diagn Invest 2011; 23(4):698703.
  • 45
    Paltrinieri S, Meazza C, Giordano A, et al. Validation of thromboelastometry in horses. Vet Clin Pathol 2008; 37(3):277285.
  • 46
    Jeger V, Zimmermann H, Exadaktylos AK. Can RapidTEG accelerate the search for coagulopathies in the patient with multiple injuries? J Trauma 2009; 66(4):12531257.
  • 47
    Kashuk JL, Moore EE, Wohlauer M, et al. Initial experiences with point-of-care rapid thrombelastography for management of life-threatening postinjury coagulopathy. Transfusion 2012; 52(1):2333.
  • 48
    Cotton BA, Faz G, Hatch QM, et al. Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission. J Trauma 2011; 71(2):407414; discussion 414–407.
  • 49
    Pezold M, Moore EE, Wohlauer M, et al. Viscoelastic clot strength predicts coagulation-related mortality within 15 minutes. Surgery 2012; 151(1):4854.
  • 50
    Jeger V, Willi S, Liu T, et al. The Rapid TEG alpha-angle may be a sensitive predictor of transfusion in moderately injured blunt trauma patients. ScientificWorldJournal 2012; 2012: 821794.
  • 51
    Kashuk JL, Moore EE, Sabel A, et al. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery 2009; 146(4):764772; discussion 772–764.
  • 52
    Cotton BA, Minei KM, Radwan ZA, et al. Admission rapid thrombelastography predicts development of pulmonary embolism in trauma patients. J Trauma Acute Care Surg 2012; 72(6):14701475; discussion 1475–1477.